• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

CI-921混合胶束的制备及透析拟合法测定胶束的包封率

周卫赛, 吴子梅, BAGULEY Bruce C., 李彩宾, 张文丽, 刘建平

周卫赛, 吴子梅, BAGULEY Bruce C., 李彩宾, 张文丽, 刘建平. CI-921混合胶束的制备及透析拟合法测定胶束的包封率[J]. 中国药科大学学报, 2016, 47(5): 575-580. DOI: 10.11665/j.issn.1000-5048.20160512
引用本文: 周卫赛, 吴子梅, BAGULEY Bruce C., 李彩宾, 张文丽, 刘建平. CI-921混合胶束的制备及透析拟合法测定胶束的包封率[J]. 中国药科大学学报, 2016, 47(5): 575-580. DOI: 10.11665/j.issn.1000-5048.20160512
ZHOU Weisai, WU Zimei, BAGULEY Bruce C., LI Caibin, ZHANG Wenli, LIU Jianping. Preparation of CI-921 mixed micelles and determination of its entrapment efficiency by method of dialysis and fitting[J]. Journal of China Pharmaceutical University, 2016, 47(5): 575-580. DOI: 10.11665/j.issn.1000-5048.20160512
Citation: ZHOU Weisai, WU Zimei, BAGULEY Bruce C., LI Caibin, ZHANG Wenli, LIU Jianping. Preparation of CI-921 mixed micelles and determination of its entrapment efficiency by method of dialysis and fitting[J]. Journal of China Pharmaceutical University, 2016, 47(5): 575-580. DOI: 10.11665/j.issn.1000-5048.20160512

CI-921混合胶束的制备及透析拟合法测定胶束的包封率

基金项目: 国家自然科学基金资助项目(No.81503005);江苏省自然科学基金资助项目(No.BK20140669);江苏高校优势学科建设工程资助项目

Preparation of CI-921 mixed micelles and determination of its entrapment efficiency by method of dialysis and fitting

  • 摘要: 研制CI-921混合胶束(CI-Micelles),建立CI-Micelles包封率的测定方法,并对胶束进行处方优化和体外表征。采用薄膜分散法制备CI-Micelles,通过透析法分离CI-Micelles的游离药物和载药胶束,测定药物含量,得到包封率和载药量的测定值,利用方程拟合法推算出CI-Micelles包封率和载药量的真实值。考察聚合物的总量、两种聚合物用量的比例和水合介质的种类对胶束粒径分布、包封率和载药量的影响;考察载药胶束4 ℃下6 d内的放置稳定性。结果表明,以总聚合物浓度为72 mg/mL,Pluronic F127与Solutol HS15质量之比为1∶2,5%葡萄糖溶液为水合介质时制备的CI-Micelles具有最佳的包封率(>;90%)和粒径分布(17~25 nm,分布系数<;0.210),在4 ℃下放置6 d,包封率及粒径均无显著变化。本实验所建立的新型包封率的测定方法——透析拟合法可以用来考察难以达到漏槽条件的弱碱性药物小粒径胶束的包封率。利用混合配比的聚合物材料Pluronic F127和Solutol HS15制备的CI-Micelles粒径分布均匀,包封率和载药量高,稳定性较好。
    Abstract: The aim of this research were to prepare CI-921 mixed micelles(CI-Micelles), to establish a method for determining the entrapment efficiency of CI-Micelles, to optimize the formulation and to evaluate their in vitro properties. CI-Micelles were prepared by film dispersion. Dialysis and fitting were used to calculate true entrapment efficiency(EE)and drug loading(DL)of CI-Micelles. The influences of polymer concentration, polymer radio and hydrating media on the entrapment efficiency, drug loading and particle-size were investigated. The stability at 4 °C in 6 days was evaluated. The optimal formulation of CI-921-Micelles consisting of polymer concentration of 72 mg/mL, a mass radio of Pluronic F127/Solutol HS15 at mass ratio of 1 ∶2 and 5% glucose solution as hydrating medium, showed a EE of more than 90%, and mean particle-size of 17-25 nm and PDI< 0. 210. There were no significant changes to CI-Micelles in EE and particle-size after treatment at 4 °C for 6 days. The applied method of dialysis and fitting could be used to determine EE for micelles loaded with weakly basic drug which was difficult to meet sink conditions. Adjustment of the mass radio of Pluronic F127 to Solutol HS15 had resulted in uniform particle size distribution, high entrapment efficiency and drug loading capacity and better stability of CI-Micelles.
  • [1] Schneider E,Darkin SJ,Lawson PA,et al.Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide:role of DNA topoisomerase II[J].Eur J Cancer Clin Oncol,988,24(11):1783-1787,1789-1790.
    [2] Baguley BC,Denny WA,Atwell GJ,et al.Synthesis,antitumor activity,and DNA Binding properties of a new derivative of amsacrine,N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4-acridinecarboxamide[J].Cancer Res,1984,44(8):3245-3251.
    [3] See E,Zhang W,Liu J,et al.Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading:Stability,solubility,lipophilicity and ionization[J].Int J Pharm,2014,473(1/2):528-535.
    [4] Zhang W, Wang G, Falconer JR, et al. Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug[J].Pharm Res,2014,32(4):1-11.
    [5] Fyfe D,Price C,Langley RE,et al.A phase I trial of amsalog(CI-921)administered by intravenous infusion using a 5-day schedule[J].Cancer Chemother Pharmacol,2001,47(4):333-337.
    [6] Zhao LJ,Liu DH,Liu ZH,et al.Preparation and characterization of docetaxel loaded Pluronic F127 polymeric micelles[J].Chin J Bio Pharm(中国生化药物杂志),2011,32(2):107-110.
    [7] Li YY,Li L,Dong HQ,et al.Pluronic F127 nanomicelles engineered with nuclear localized functionality for targeted drug delivery[J].Mater Sci Eng C Mater Biol Appl,2013,33(5):2698-2707.
    [8] Taha EI,Badran MM,El-Anazi MH,et al.Role of Pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin[J].J Mol Liq,2014,199(9):251-256.
    [9] Cai Z,Pan WH.Honokiol/Pluronic F-127 micelles:preparation and its in vitro anti-tumor study[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(2):186-189.
    [10] Attia ABE,Zhan YO,Hedrick JL,et al.Mixed micelles self-assembled from block copolymers for drug delivery[J].Curr Opin Colloid In,2011,16(3):182-194.
    [11] Li JF,Gao MY,Wang HM,et al.Optimization and in vitro characterization of resveratrol-loaded poloxamer 403/407 mixed micelles[J].J China Pharm Univ(中国药科大学学报),2015,50(8):1045-1051.
    [12] Zhang W,Hao J,Shi Y,et al.Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles:formulation,optimization and in vitro characterization[J].Int J Pharm,2009,376(1/2):176-185.
    [13] Chen ZH,Liu GY,Wei YC.The research progress of methods of determining the entrapment efficiency of liposomes[J].Pharm J China PLA(解放军药学学报),2011,27(1):79-82.
    [14] Gao L,Jin LN,Hong YE,et al.Determination of entrapment efficiency of methylprednisolone hemisuccinate loaded polymeric micelles[J].Acad Guangdong Coll Pharm(广东药学院学报),2014,30(1):15-18.
    [15] Chen Y,Gu X.Preparation of bionic lovastatin-loaded nanostructured lipid carrier and its in vitro targeting and in vivo pharmacokinetics in rabbits[J].J China Pharm Univ(中国药科大学学报),2014,45(5):544-550.
    [16] Zhang W,Wang G,See E,et al.Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation,superior to PEGylation[J].J Control Release,2015,203(4):161-169.
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 刊出日期:  2016-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭